NCT04307108

Brief Summary

Background: Virtual Reality (VR) technology may help to provide a way for stroke survivors to exercise in their own time at home, with remote clinical support. Before we introduce this technology we need to test that it will work alongside current health services for stroke survivors. Aims: To find out if using the MAGIC-GLASS solution alongside current healthcare care is usable and acceptable to stroke survivors and helps to increase rehabilitation time. Design: Measures before and after stroke survivors use the MAGIC-GLASS solution. Setting: Stroke survivors will use the MAGIC-GLASS solution in their own home. Population: adults (≥18 years) who have had a stroke at least two weeks before they enter into the study. Interventions: Our VR technology is called MAGIC-GLASS, and in order to use the solution the user puts on a headset which is connected to a computer. They can then see a VR environment in which they will be able to see virtual hands that respond to the movements of their own hands. It will also be possible to see a mirror image of their hands moving. The system will record how much they use the system and improvement in their movement. Regular contact will be made with a clinician who will be able to use the system to see (from their clinic) how the stroke survivor is doing and talk to them. Outcomes: We want to find out how the stroke survivors' movement changes over time and what they think of using the system. We will also ask clinical staff what they thought of using the system as part of healthcare provision to stroke survivors. Finally we want to find out how much it will cost to use the system.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable stroke

Timeline
Completed

Started Nov 2018

Geographic Reach
2 countries

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 11, 2018

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

February 17, 2020

Completed
25 days until next milestone

First Posted

Study publicly available on registry

March 13, 2020

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2020

Completed
Last Updated

March 13, 2020

Status Verified

March 1, 2020

Enrollment Period

1.4 years

First QC Date

February 17, 2020

Last Update Submit

March 10, 2020

Conditions

Keywords

stroke, virtual reality, upper limb

Outcome Measures

Primary Outcomes (7)

  • the usability of the intervention;

    Combination of interviews with users, carer questionnaire, focus groups with clinicians will be used to assess usability using qualitative analysis

    through study completion, an average of 6 months

  • the usability of the intervention

    System usability score questionnaire

    through study completion, an average of 6 months

  • the acceptability of the intervention

    Combination of interviews with users, carer questionnaire, focus groups with clinicians will be used to assess acceptability by analysing qualitatively

    through study completion, an average of 6 months

  • the process requirements for the new care pathway;

    Combination of interviews with users, carer questionnaire, focus groups with clinicians and will be analysed qualitatively

    through study completion, an average of 6 months

  • the resource requirements for the new care pathway;

    Combination of interviews with users, carer questionnaire, focus groups with clinician and will be analysed qualitatively

    through study completion, an average of 6 months

  • the intensity in Rehabilitation Therapy

    measured in clinical dashboard

    Change from baseline to end of intervention (6 months)

  • the duration in Rehabilitation Therapy

    measured in clinical dashboard

    Change from baseline to end of intervention (6 months)

Secondary Outcomes (6)

  • Functional independence in the activities of daily living with respect to the modified Rankin Scale

    Change from baseline to end of intervention (6 months)

  • Functional independence in the activities of daily living with respect to the Barthel Index

    Change from baseline to end of intervention (6 months)

  • physical activity as measured by range of motion

    Change from baseline to end of intervention (6 months)

  • cognitive function

    Change from baseline to end of intervention (6 months)

  • Stroke specific quality of life

    Change from baseline to end of intervention (6 months)

  • +1 more secondary outcomes

Interventions

MAGIC-GLASS is a VR-based home system for stroke rehabilitation, developed by Ulster University (UK) in collaboration with Tech4Care srl (Italy) and miThings AB (Sweden) in the context of the EU-funded Project Magic (grant agreement No 687228). It includes a number of mini-games grounded on rehabilitation paradigms such as mirror therapy \[29\] and can adapt to the capability of a person. In addition, the games will include an automatic coaching system for giving feedback both on rehabilitation results (e.g. achievement of exercise goals) and performance (during the exercise itself, the system will give real time advice on the execution of the exercise).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any time point post stroke
  • Medically stable (and without uncontrolled seizures or vertigo)
  • No or mild cognitive deficit: can follow two step commands
  • No significant visual or spatial neglect (Can turn head towards an image when asked to do so and keep attention). People with hemianopia or other visual deficits can be included dependent on clinical opinion
  • Normal or normal corrected vision
  • Be able to get in and out from a seat with assistance; can be used in a wheelchair as long as arms can rest on table
  • Have a carer to assist putting on the headset
  • Be willing to give consent
  • For those not using mirror therapy, can move impaired arm without significant pain

You may not qualify if:

  • People with a moderate to severe cognitive impairment (MoCA\<20).
  • Those with a visual impairment who are unable to see a clear image with the headset.
  • Patients with severe neuropsychological deficits such as severe neglect or apraxia as indicated by their clinical team.
  • Patients who are medically unwell e.g. with history of solid organ or bone marrow transplantation, active malignancy within 24 months prior to screening or metastatic cancer, life expectancy less than 6 months, Congestive heart failure in New York Heart Association (NYHA) Functional Classification IV (severe) stage.
  • Those with complete dependency in Activities of Daily Living, any medical or other reason (e.g. known or suspected inability of the participant to comply with the protocol procedure) that investigator opinion that the participant is unsuitable for the study.
  • Patients unwilling to provide consent and those who cannot be followed-up at any time point will be excluded from the study.
  • Those with upper limb sensory disturbance who are unwilling to keep their nails short for the duration of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Neuro-rehabilitation Department of the University Hospital of Ancona.

Ancona, Italy

RECRUITING

Western Health and Social Care Trust

Londonderry, United Kingdom

RECRUITING

Southern Health and Social Care Trust

Lurgan, United Kingdom

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Aoife Stephenson, PhD

CONTACT

Suzanne McDonough, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2020

First Posted

March 13, 2020

Study Start

November 11, 2018

Primary Completion

March 30, 2020

Study Completion

June 10, 2020

Last Updated

March 13, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations